Find-Health-Articles.com - making medical research available to everyone

Propylamines
Research News and Information

Sunday, November 22, 2009

1,3-Diazido-2-(azidomethyl)-2-propylammonium salts.

5 Sep 2009 New energetic inorganic materials composed of 1,3-diazido-2-(azidomethyl)-2-propylammonium salts have been fully characterized by IR, (1)H, (13)C, and (15)N NMR spectroscopy and by elemental analyses, as well as single crystal X-ray diffraction. In ... Read more...


[Attention Deficit Hyperactivity Disorder (ADHD) and road traffic - special considerations for the treatment of adolescents with ADHD]

30 Aug 2009 Attention Deficit Hyperactivity Disorder (ADHD) is not only a childhood disorder but symptoms persist into adolescence and adulthood in approximately one third of the patients. Especially inattention and poor concentration impair driving performance ... Read more...


Use of atomoxetine in patients with attention-deficit hyperactivity disorder and co-morbid conditions.

30 Aug 2009 Attention-deficit hyperactivity disorder (ADHD) is one of the most common neurobehavioural disorders in children. It has been shown that as many as 85% of patients with ADHD have at least one psychiatric co-morbidity, and approximately 60% have at ... Read more...

 

Latest indexed articles for 'Propylamines'

These are the very latest articles for this heading:

See a longer list of these articles.

Technical information about 'Propylamines'

Registry Number: 0

Descriptor UI: D011437

Alternative terms: Propylamines;

Allowable Qualifiers: administration & dosage; adverse effects; analysis; antagonists & inhibitors; blood; cerebrospinal fluid; chemical synthesis; classification; diagnostic use; economics; history; immunology; isolation & purification; metabolism; pharmacokinetics; pharmacology; poisoning; radiation effects; standards; supply & distribution; therapeutic use; toxicity; urine; chemistry; contraindications; agonists;

Tree Number: D02.092.831;

History Note: 66

© Advanogy LLC 2003-2009 - All rights reserved. Terms of Use | Contact Us | Index